Beckman Coulter Launches New Hepatitis Assays on its DxI 9000 Immunoassay Analyzer

Beckman Coulter Diagnostics has expanded the menu of assays available on its DxI 9000 Immunoassay Analyzer following CE mark approval of tests for hepatitis B and C viruses, namely Access anti-HCV, Access HBsAg and Access HBsAg Confirory assays.

Beckman Coulter’s validated HBsAg High Positive algorithm eliminates the need for repeat and confirmatory testing for samples ≥ 100.00 S/CO and can directly report 96.9% of initially reactive specimens as positive, providing laboratories with accurate results. The assay is intended to be used as an aid in the diagnosis of HBV infection and as a screening test for blood and plasma donors.

To view the source version, please click HERE.